Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 12Recruiting 3Active not recruiting 3Unknown 2Terminated 2Suspended 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 4Breast 3Tumor-Agnostic 2Other hematologic neoplasm 2Gynecologic 2Gastrointestinal 2CNS 2Head & Neck 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 2Vulvar Neoplasms 1Vomiting 1Stomach Neoplasms 1Pancreatic Neoplasms 1Nausea 1Endometrial Neoplasms 1Anus Neoplasms 1

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interviews as Topic × Gynecologic × Clear all
NCT00394602 2020-01-02

Chemoradiation-Induced Nausea and Emesis: Quality of Life

M.D. Anderson Cancer Center

Terminated
207 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Nausea, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Vulvar Neoplasms, Endometrial Neoplasms

NCT03613493 2019-08-02

Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention

University of Miami

Phase NA Terminated
175 enrolled 8 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡